MedTrace Logo

Targeting Inflammation for Endometrial Cancer Prevention

NCT05407025 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 191

Last updated 2025-12-19

No results posted yet for this study

Summary

This study examines risk assessment and identifies prevention strategies for endometrial cancer. Collecting samples of blood and urine and risk assessments from patients with benign conditions or endometrial cancer may help doctors learn if there is a relationship between chronic inflammation and increase in risk for endometrial cancer.

Conditions

  • Endometrial Carcinoma

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of blood, urine, and tissue samples

OTHER

Questionnaire Administration

Complete risk factor questionnaire

Sponsors & Collaborators

Principal Investigators

  • Mark E. Sherman, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05407025 on ClinicalTrials.gov